Cargando…

1065. Patient-Reported Reasons for Non-Participation in Inpatient COVID-19 Clinical Research: Results from a Multi-Center VA Embedded Randomized Trial

BACKGROUND: Early in the COVID-19 pandemic, no evidence-proven therapeutics were approved, and thus participation in a clinical trial was often the only way to access experimental medications. However, in the US, participation in medical research is low. Patient-stated factors impacting enrollment d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reyes Dassum, Samira, Ferguson, Ryan, Woods, Patricia, Flynn, Maura, Visnaw, Karen, Schiller, Sara J, Monach, Paul, Leatherman, Sarah, Branch-Elliman, Westyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752147/ http://dx.doi.org/10.1093/ofid/ofac492.906

Ejemplares similares

Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation
por: Dassum, Samira Reyes, et al.
Publicado: (2023)

Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial
por: Woods, Patricia, et al.
Publicado: (2021)

517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial
por: Branch-Elliman, Westyn, et al.
Publicado: (2021)

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial
por: Branch-Elliman, Westyn, et al.
Publicado: (2022)

Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
por: Monach, Paul A, et al.
Publicado: (2021)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Moving towards a precision approach for prevention of severe COVID-19
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Bringing New Meaning to the Term “Adaptive Trial”: Challenges of Conducting Clinical Research During the Coronavirus Disease 2019 Pandemic and Implications for Implementation Science
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age?
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

2126. Comparative Effectiveness of Infection Prevention Interventions for Reducing Procedure-Related Cardiac Device Infections: Insights from the VA CART Program
por: Asundi, Archana, et al.
Publicado: (2018)

Electronic Detection of MRSA Infections in a National VA Population Augments Current Manual Process
por: Strymish, Judith, et al.
Publicado: (2017)

A Novel Informatics Tool to Detect Periprocedural Antibiotic Allergy Adverse Events for Near Real-time Surveillance to Support Audit and Feedback
por: Reyes Dassum, Samira, et al.
Publicado: (2023)

163. Development of an Electronic Flagging Tool for Identifying Cardiac Device Infections: Insights from the VA CART Program
por: Asundi, Archana, et al.
Publicado: (2018)

Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation
por: La, Jennifer, et al.
Publicado: (2022)

2656. Longitudinal Trends in Attributable Causes of Death Among US Veteran Patients with Documented SARS-CoV-2 Infection between January 2021 and March 2023
por: Trottier, Caitlin A, et al.
Publicado: (2023)

Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III)
por: Shenoy, Erica S., et al.
Publicado: (2023)

Pandemic scientific data sharing recommendations: examining and re-imagining pre-print servers after the end of the world-wide emergency
por: Doron, Shira, et al.
Publicado: (2023)

Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program
por: Asundi, Archana, et al.
Publicado: (2020)

Economic Considerations in Infectious Diseases Emergency Response Preparedness: It’s All About the Point of View
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

1101. What Do Electrophysiologists Think about Peri-Procedural Antibiotics? A Qualitative Assessment of Factors Driving Use and Facilitators for Implementing Change
por: Branch-Elliman, Westyn, et al.
Publicado: (2019)

The next ‘pandemic playbook’ needs to prioritize the needs of children—and a clear roadmap for opening schools
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study
por: Li, Lucy L., et al.
Publicado: (2022)

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2022)

Embracing dynamic public health policy impacts in infectious diseases responses: leveraging implementation science to improve practice
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

The future of automated infection detection: Innovation to transform practice (Part III/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Leveraging electronic data to expand infection detection beyond traditional settings and definitions (Part II/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
por: Fillmore, Nathanael R., et al.
Publicado: (2023)

Using the Pillars of Infection Prevention to Build an Effective Program for Reducing the Transmission of Emerging and Reemerging Infections
por: Branch-Elliman, Westyn, et al.
Publicado: (2015)

The Science Behind Safe School Re-opening: Leveraging the Pillars of Infection Control to Support Safe Elementary and Secondary Education During the COVID-19 Pandemic
por: Schechter-Perkins, Elissa M, et al.
Publicado: (2021)

1100. Facility Factors Are a Stronger Driver of Peri-Operative Vancomycin Use Than Patient Risk Factors
por: Branch-Elliman, Westyn, et al.
Publicado: (2019)

Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
por: Vo, Austin D., et al.
Publicado: (2022)

Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study
por: Fillmore, Nathanael R., et al.
Publicado: (2022)

Antiretroviral activity of aminothiols, WR2721 and WR1065
por: Poirier, Miriam C, et al.
Publicado: (2006)

Synthesis and cytotoxicity of a biotinylated CC-1065 analogue
por: Wang, Yuqiang, et al.
Publicado: (2002)

111. Increasing Duration of Surgical Prophylaxis Increases Antimicrobial-Associated Adverse Events but Does Not Decrease Surgical Site Infections: An Opportunity for Stewardship
por: Strymish, Judith M, et al.
Publicado: (2018)

858. Preoperative “Dirty” Urinalysis Leads to Antibiotic Use Without Benefit
por: Gallegos, Jaime, et al.
Publicado: (2018)

1065. Evaluation of a Staphylococcus aureus Bacteremia Treatment Checklist
por: Soukup, Hailey, et al.
Publicado: (2018)

National Cohort Study of Preoperative Bacteriuria, Surgical Prophylaxis, and Postoperative Outcomes
por: GallegosSalazar, Jaime, et al.
Publicado: (2017)

How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols
por: Asundi, Archana, et al.
Publicado: (2021)

212. Measuring the Morbidity of Infectious Complications of the Opiate Epidemic: A Retrospective Cohort Study
por: Harvey, Leah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u561d03r5nlu9fn93dvgtpo0r0